Increased Secretion of Lipoproteins in Transgenic Mice Expressing Human D374Y PCSK9 Under Physiological Genetic Control
Author(s) -
Bronwen Herbert,
Dilipkumar Patel,
Simon N. Waddington,
Emily R. Eden,
Alexandra McAleenan,
XiMing Sun,
Anne K. Soutar
Publication year - 2010
Publication title -
arteriosclerosis thrombosis and vascular biology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.007
H-Index - 270
eISSN - 1524-4636
pISSN - 1079-5642
DOI - 10.1161/atvbaha.110.204040
Subject(s) - pcsk9 , kexin , transgene , genetically modified mouse , ldl receptor , biology , endocrinology , lipoprotein , bacterial artificial chromosome , medicine , cholesterol , mutant , triglyceride , receptor , familial hypercholesterolemia , gene , biochemistry , genome
To produce transgenic mice expressing the D374Y variant of the human proprotein convertase subtilisin/kexin type 9 (PCSK9) gene at physiological levels to investigate the mechanisms causing hypercholesterolemia and accelerated atherosclerosis.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom